Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Amazon.com Inc.

Start price
Target price
Perf. (%)
€131.10
31.10.20
€150.00
04.11.21
1.96%
14.11.20

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
buy
Agilent Technologies Inc.

Start price
Target price
Perf. (%)
€89.88
30.10.20
-
04.11.21
7.35%
03.01.21

Higher EBIT margin than peer group
Market Leader or Top 3
Known brand
Future proof or reliable business model
buy
Microsoft Corp.

Start price
Target price
Perf. (%)
€174.42
30.10.20
€285.00
04.11.21
66.27%
04.11.21

Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Amazon.com Inc.

Start price
Target price
Perf. (%)
€130.18
30.10.20
€135.00
02.11.20
0.71%
02.11.20

Could be worthwhile Investment >10% per year
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€224.55
30.10.20
-
31.10.20
1.09%
31.10.20

Some uniques
Risky Investment
buy
miRagen Therapeutics Inc

Start price
Target price
Perf. (%)
€24.75
30.10.20
€45.00
02.11.20
-39.39%
02.11.20

Risky Investment
buy
Charles Schwab Corp.

Start price
Target price
Perf. (%)
€34.40
29.10.20
-
04.11.21
26.48%
01.01.21

negative Cash Flow expected
Revenue decline/stagnation expected
High valuation
Low dividend yield expected
buy
Apple Inc.

Start price
Target price
Perf. (%)
€96.02
29.10.20
€140.00
04.11.21
36.97%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€236.70
29.10.20
€245.00
30.10.20
-5.13%
30.10.20

Some uniques
Risky Investment
buy
eBay Inc.

Start price
Target price
Perf. (%)
€43.61
29.10.20
€45.00
04.11.21
-7.56%
11.11.20

Growths faster than the competition
Risky Investment
buy
Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€371.00
29.10.20
-
04.11.21
8.65%
30.12.20

EBIT growth >5% per year expected
Very low/no dividend yield expected
Cocrystal Pharma Inc.

Start price
Target price
Perf. (%)
€8.64
28.10.20
-
04.11.21
31.94%
15.07.21

Could be very worthwhile Investment >20% year
Aytu Biopharma Inc.

Start price
Target price
Perf. (%)
€160.00
28.10.20
-
04.11.21
-54.25%
15.07.21

Risky Investment
Outdated or very high risk business model
Expedia Inc.

Start price
Target price
Perf. (%)
€79.34
28.10.20
€76.00
04.11.21
6.02%
04.11.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Good rating
Splunk Inc.

Start price
Target price
Perf. (%)
€176.36
28.10.20
€159.00
04.11.21
0.77%
04.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
International Business Machines Corp

Start price
Target price
Perf. (%)
€90.20
28.10.20
€89.00
04.11.21
9.18%
13.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Socket Mobile Inc.

Start price
Target price
Perf. (%)
€3.20
28.10.20
€2.00
31.10.20
-31.88%
31.10.20

Risky Investment
buy
Alphabet Inc. A

Start price
Target price
Perf. (%)
€67.04
28.10.20
€0.090
04.11.21
91.60%
05.11.21

Could be worthwhile Investment >10% per year
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€267.50
27.10.20
€300.00
31.10.20
8.41%
31.10.20

Could be worthwhile Investment >10% per year
buy
Advanced Micro Devices Inc.

Start price
Target price
Perf. (%)
€67.98
27.10.20
€72.00
04.11.21
4.30%
06.11.20

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Future proof or reliable business model
Inovio Pharma

Start price
Target price
Perf. (%)
€8.90
27.10.20
-
04.11.21
-24.99%
15.07.21

Risky Investment
Inovio Pharma

Start price
Target price
Perf. (%)
€8.90
26.10.20
-
27.10.20
0.00%
27.10.20

Risky Investment
buy
Danaher Corp.

Start price
Target price
Perf. (%)
€197.46
26.10.20
-
04.11.21
-0.33%
17.01.21

EBIT growth >5% per year expected
Revenue growth >5% per year expected
Increased challenges to pay loans and raise capital
Inovio Pharma

Start price
Target price
Perf. (%)
€8.95
26.10.20
-
26.10.20
-0.56%
26.10.20

Risky Investment
Inovio Pharma

Start price
Target price
Perf. (%)
€9.25
26.10.20
-
26.10.20
-3.24%
26.10.20

Risky Investment